# Adaptive Biotechnologies

> Adaptive Biotechnologies Corporation (Nasdaq: ADPT) is a Seattle, Washington immune-medicine
> company that sequences and interprets the adaptive immune system. Its clonoSEQ assay is an
> FDA-cleared next-generation sequencing test for measurable residual disease (MRD) in blood
> cancers; its immunoSEQ assays, immunoSEQ Analyzer and immuneACCESS repository serve research;
> and its MRD biopharma services support drug development. Adaptive sells laboratory tests and
> services, not software. As of 2026-09-07 it publishes no developer portal, no public API
> reference, no SDK and no machine-readable specification of any kind.

## What this file is

This llms.txt was generated by API Evangelist from an independent third-party profile of
Adaptive Biotechnologies' public surface. It is not published by Adaptive Biotechnologies and
does not live on an Adaptive host. Source profile:
https://github.com/api-evangelist/adaptive-biotechnologies

## API surface

- [No public API](https://www.adaptivebiotech.com/): probed 2026-09-07 — /openapi.json,
  /openapi.yaml, /swagger.json, /api-docs, /v1/openapi.json, /llms.txt, /apis.json and the full
  named /.well-known set return HTTP 404 on www.adaptivebiotech.com, adaptivebiotech.com,
  clients.adaptivebiotech.com and www.clonoseq.com. No GraphQL, no MCP server, no A2A agent
  card, no AsyncAPI, no gRPC and no WSDL was found.
- [clonoSEQ EMR integration](https://www.clonoseq.com/emr-integration/): the real integration
  surface. clonoSEQ orders and results move through Epic (including Epic Aura), Flatiron
  Health's OncoEMR via Molecular Profiling Integration, and Carequality / health information
  exchanges. Access is arranged with Adaptive's integration specialists at
  emrsupport@adaptivebiotech.com; an Epic build is described as an 8–12 week project. No
  interface specification is published.
- [immunoSEQ Analyzer](https://clients.adaptivebiotech.com/login): cloud analysis application
  for immunoSEQ data, behind a customer login. No API is documented for it.
- [immuneACCESS](https://clients.adaptivebiotech.com/immuneaccess): public immune-repertoire
  data repository. Access is open but registration-gated, via download in the web application;
  no programmatic interface is published.

## Company

- [Website](https://www.adaptivebiotech.com/)
- [Who we are](https://www.adaptivebiotech.com/who-we-are/)
- [Immune Medicine Platform](https://www.adaptivebiotech.com/our-platform/)
- [clonoSEQ MRD test](https://www.adaptivebiotech.com/clonoseq-mrd-test/)
- [MRD biopharma services](https://www.adaptivebiotech.com/mrd-biopharma-services/)
- [Blog](https://www.adaptivebiotech.com/blog/)
- [Contact](https://www.adaptivebiotech.com/contact-us/)
- [Investor relations](https://investors.adaptivebiotech.com/)

## Compliance

- [Licenses and accreditation](https://www.adaptivebiotech.com/licenses-and-accreditation/):
  CAP accreditation, CLIA license, ISO 13485, MDSAP, EU IVDR, ISO 27001, and CA/MD/NY/PA/RI
  clinical laboratory licenses.
- [HIPAA notice](https://www.adaptivebiotech.com/hipaa-notice/)
- [Terms of service](https://www.adaptivebiotech.com/terms-of-service/)
- [Privacy policy](https://www.adaptivebiotech.com/online-privacy-policy/)

## Profile artifacts

- conformance/adaptive-biotechnologies-conformance.yml — published certifications and the
  interoperability standards Adaptive does not declare
- security/adaptive-biotechnologies-domain-security.yml — probed TLS/HSTS/DNSSEC/CAA/SPF/DMARC
- well-known/adaptive-biotechnologies-well-known.yml — the /.well-known probe, all misses
- plans/adaptive-biotechnologies-plans-pricing.yml — no published plans
- rate-limits/adaptive-biotechnologies-rate-limits.yml — no published limits